Medicare Enrolled

Dr. Waqas Gilani, MD

Neurology · Sherman, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
321 N HIGHLAND AVE STE 200, Sherman, TX 75092
9039035141
In practice since 2015 (11 years)
NPI: 1386039683 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gilani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gilani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gilani

Dr. Waqas Gilani is a neurology in Sherman, TX, with 11 years in practice. Based on federal Medicare data, Dr. Gilani performed 1,197 Medicare services across 971 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gilani received a total of $9,918 from 48 pharmaceutical and/or device companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gilani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ Top 26% volume in TX$ $9,918 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,197
Medicare services
Top 26% in TX for neurology
971
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~109 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Needle measurement of electrical activity in arm or leg muscles, complete study244$69$171
Office visit, established patient (30-39 min)215$87$171
Office visit, established patient, complex (40-54 min)208$119$240
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face112$82$500
Office visit, established patient (20-29 min)85$62$113
Measurement of brain wave activity (eeg), awake and drowsy71$260$523
Nerve conduction, 7-8 studies47$114$448
Smoking and tobacco use intensive counseling, 4-10 minutes45$13$47
Nerve conduction, 13 or more studies42$210$732
Injection of chemical for paralysis of nerve muscles on side of face31$117$743
Nerve conduction, 11-12 studies29$181$632
EEG, extended monitoring17$309$602
Smoking and tobacco use intensive counseling, more than 10 minutes15$26$68
Nerve conduction, 3-4 studies13$76$193
New patient office visit, complex (60-74 min)12$139$326
Nerve conduction, 9-10 studies11$155$459
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,918
Total received (2020-2024)
Avg $1,984/year across 5 years
Top 28% in TX for neurology
48
Companies
378
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,862 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$57 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,532
2023
$2,251
2022
$3,493
2021
$2,434
2020
$209

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
LivaNova USA, Inc.
$1,668
Biogen, Inc.
$1,264
Novartis Pharmaceuticals Corporation
$761
ABBVIE INC.
$460
PFIZER INC.
$442
AbbVie Inc.
$347
Biohaven Pharmaceutical Holding Company Ltd.
$331
Teva Pharmaceuticals USA, Inc.
$327
Biohaven Pharmaceuticals, Inc.
$320
Alexion Pharmaceuticals, Inc.
$293
Amneal Pharmaceuticals LLC
$272
SK Life Science, Inc.
$266
JAZZ PHARMACEUTICALS INC.
$263
Inspire Medical Systems, Inc.
$253
Lundbeck LLC
$226
EMD Serono, Inc.
$177
PIRAMAL CRITICAL CARE
$159
Celgene Corporation
$159
Neurocrine Biosciences, Inc.
$146
Alnylam Pharmaceuticals Inc.
$140
Allergan, Inc.
$139
GENZYME CORPORATION
$127
ACADIA Pharmaceuticals Inc
$115
Otsuka America Pharmaceutical, Inc.
$109
Genentech USA, Inc.
$101
UCB, Inc.
$97
Harmony Biosciences LLC
$91
Eisai Inc.
$80
Lilly USA, LLC
$78
Avanir Pharmaceuticals, Inc.
$77
Acorda Therapeutics, Inc
$77
AstraZeneca Pharmaceuticals LP
$71
HARMONY BIOSCIENCES LLC
$69
Medtronic, Inc.
$66
Greenwich Biosciences, Inc.
$55
Amgen Inc.
$46
Sumitomo Pharma America, Inc.
$41
CSL Behring
$28
Janssen Pharmaceuticals, Inc
$27
ANI Pharmaceuticals, Inc.
$22
Sunovion Pharmaceuticals Inc.
$20
IMPEL PHARMACEUTICALS INC.
$18
Boston Scientific Corporation
$17
TG THERAPEUTICS, INC.
$17
Averitas Pharma Inc.
$16
CATALYST PHARMACEUTICALS, INC.
$15
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
Neurelis, Inc.
$13
Top 3 companies account for 37.2% of total payments
Associated products mentioned in payments ›
ACTIVA · AJOVY · AMVUTTRA · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BOTOX · BRILINTA · BRIUMVI · Briviact · COMIRNATY · DUOPA · EPIDIOLEX · Epidiolex · FIRDAPSE · Fintepla · GABLOFEN · Hizentra · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NEXVIAZYME · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · ONPATTRO · Ocrevus · Ongentys · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUTENZA · RADICAVA · REXULTI · REYVOW · RYTARY · SOLIRIS · Skyclarys · Soliris · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · WAINUA · WAKIX · Wakix · WaveWriter Alpha Prime 16 · XCOPRI · XYWAV · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $829 per 100 Medicare services performed
Looking for a neurology in Sherman?
Compare neurologys in the Sherman area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
20
Per 100K population
14.3
County median income
$70,455
Nearest hospital
WILSON N JONES REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gilani is a clinical cardiology specialist, with above-average Medicare volume (top 26% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gilani experienced with needle measurement of electrical activity in arm or leg muscles, complete study?
Based on Medicare claims data, Dr. Gilani performed 244 needle measurement of electrical activity in arm or leg muscles, complete study services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gilani receive payments from pharmaceutical companies?
Yes. Dr. Gilani received a total of $9,918 from 48 companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gilani's costs compare to other neurologys in Sherman?
Dr. Gilani's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gilani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →